{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T06:22:36Z","timestamp":1775370156016,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.antiviral.2010.10.003","type":"journal-article","created":{"date-parts":[[2010,10,17]],"date-time":"2010-10-17T08:13:53Z","timestamp":1287303233000},"page":"325-328","source":"Crossref","is-referenced-by-count":14,"title":["Antipoliovirus activity and mechanism of action of 3-methylthio-5-phenyl-4-isothiazolecarbonitrile"],"prefix":"10.1016","volume":"88","author":[{"given":"A.","family":"Garozzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Stivala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Tempera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2010.10.003_bib0005","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1128\/AAC.48.5.1766-1772.2004","article-title":"In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: novel capsid-binding inhibitors with potent antipicornavirus activity","volume":"48","author":"Barnard","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2010.10.003_bib0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.antiviral.2008.04.002","article-title":"A case for developing antiviral drugs against polio","volume":"79","author":"Collett","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2010.10.003_bib0015","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/S0968-0896(98)80007-2","article-title":"Synthesis and antiviral activity of a new series of 4-isothiazolecarbonitriles","volume":"6","author":"Cutr\u00ec","year":"1998","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2010.10.003_bib0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0968-0896(98)00237-5","article-title":"Synthesis of new 3,4,5-trisubstituted isothiazoles as effective inhibitory agents of enteroviruses","volume":"7","author":"Cutr\u00ec","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2010.10.003_bib0025","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0166-3542(02)00072-4","article-title":"Synthesis of new 3-methylthio-5-aryl-4-isothiazolecarbonitriles with broad antiviral spectrum","volume":"55","author":"Cutr\u00ec","year":"2002","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2010.10.003_bib0030","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/095632020401500403","article-title":"Isothiazole derivatives as novel HIV replication inhibitors","volume":"15","author":"Cutr\u00ec","year":"2004","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2010.10.003_bib0035","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3201\/eid1404.070439","article-title":"Potential use of antiviral agents in polio eradication","volume":"14","author":"De Palma","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2010.10.003_bib0040","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/med.20125","article-title":"Selective inhibitors of picornavirus replication","volume":"28","author":"De Palma","year":"2008","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.antiviral.2010.10.003_bib0045","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0042-6822(76)90288-9","article-title":"Studies on the in vitro uncoating of poliovirus. I. Characterization of the modifying factor and the modifying reaction","volume":"70","author":"De Sena","year":"1976","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2010.10.003_bib0050","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0166-3542(94)90094-9","article-title":"Antiviral capsid-binding compounds can inhibit the adsorption of minor receptor rhinoviruses","volume":"25","author":"Dewindt","year":"1994","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2010.10.003_bib0055","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1592\/phco.23.3.339.32099","article-title":"Pleconaril, a novel antipicornaviral agent","volume":"2","author":"Florea","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.antiviral.2010.10.003_bib0060","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1128\/JVI.64.5.1934-1945.1990","article-title":"Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding","volume":"64","author":"Fricks","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.10.003_bib0065","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0166-3542(00)00072-3","article-title":"Antirhinovirus activity of 3-methylthio-5-aryl-4-isothazolecarbonitrile derivatives","volume":"45","author":"Garozzo","year":"2000","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2010.10.003_bib0070","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/095632020701800503","article-title":"Isothiazole derivatives as antiviral agents","volume":"18","author":"Garozzo","year":"2007","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2010.10.003_bib0075","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.micro.56.012302.160757","article-title":"Poliovirus cell entry: common structural themes in viral cell entry pathways","volume":"56","author":"Hogle","year":"2002","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2010.10.003_bib0080","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.bmcl.2008.12.078","article-title":"3,4-Disubstituted isothiazoles: novel potent inhibitors of VEGF receptors 1 and 2","volume":"19","author":"Kiselyov","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2010.10.003_bib0085","first-page":"485","article-title":"Synthesis of new 4 and 5 disubstituted isothiazoles","volume":"36","author":"Kuczynski","year":"1984","journal-title":"Pol. J. Pharmacol. Pharm."},{"key":"10.1016\/j.antiviral.2010.10.003_bib0090","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.mi.46.100192.003223","article-title":"Treatment of the picornavirus common cold by inhibitors of viral uncoating and attachment","volume":"46","author":"McKinlay","year":"1992","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2010.10.003_bib0095","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1128\/AAC.43.10.2444","article-title":"In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease","volume":"43","author":"Patick","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2010.10.003_bib0100","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1128\/AAC.49.6.2267-2275.2005","article-title":"In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease","volume":"49","author":"Patick","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2010.10.003_bib0105","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1006\/jmbi.1995.0637","article-title":"A novel basis of capsid stabilization by antiviral compounds","volume":"254","author":"Phelps","year":"1995","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2010.10.003_bib0110","doi-asserted-by":"crossref","first-page":"11378","DOI":"10.1073\/pnas.93.21.11378","article-title":"Early events in poliovirus infection: virus-receptor interactions","volume":"93","author":"Racaniello","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2010.10.003_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(97)00068-5","article-title":"Treatment of human enterovirus infections","volume":"38","author":"Rotbart","year":"1998","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2010.10.003_bib0120","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1158\/1535-7163.MCT-05-0135","article-title":"Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity","volume":"4","author":"Stimson","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.antiviral.2010.10.003_bib0125","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1016\/j.bmcl.2006.05.019","article-title":"Discovery of 3-hydroxy-4-carboxyalkylamidino-5-arylamino-isothiazoles as potent MEK1 inhibitors","volume":"16","author":"Varaprasad","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2010.10.003_bib0130","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1039\/p19720001247","article-title":"Isothiazoles. XV. 5-Nitroisothiazoles","volume":"1","author":"Walsh","year":"1972","journal-title":"J. Chem. Soc., Perkin Trans."},{"key":"10.1016\/j.antiviral.2010.10.003_bib0135","series-title":"Advances in Heterocyclic Chemistry","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0065-2725(08)60951-4","article-title":"Recent advances in the chemistry of mononuclear isothiazoles","author":"Wooldridge","year":"1972"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354210007618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354210007618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T00:41:35Z","timestamp":1592008895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354210007618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0166354210007618"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2010.10.003","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}